Skip to content

Interdisciplinary Rehabilitation of Patients With Glioma During Anti-cancer Treatment

Interdisciplinary Rehabilitation of Patients With Glioma During Anti-cancer Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02221986
Enrollment
64
Registered
2014-08-21
Start date
2015-02-01
Completion date
2018-02-14
Last updated
2018-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CNS Neoplasms, Neoplasms

Keywords

Interdisciplinary rehabilitation, Neurooncology, Physiotherapy, Occupational therapy, Neurorehabilitation, Glioma

Brief summary

The results of the present RCT study will add to the growing body of literature investigating the potential role of exercise as a supportive therapeutic intervention for patient with glioma.

Detailed description

Gliomas are the most frequent primary neoplasm in the CNS and according to the World Health Organization histologically categorized into low-grade glioma (LGG) (WHO grades I/II) or high-grade glioma (HGG) (WHO grades III/IV). Gliomas are among the biggest challenges within the field of neuro-rehabilitation and oncology, and optimising treatment by improving QoL, function and cognition is of major clinical importance in this population. Because the majority of patients cannot be cured, clinical cancer research traditionally have focused on prolonging survival, exposing relapse or optimising the response to the medical treatment. Today there is a general consensus that health-related quality of life (HRQoL) is important in the evaluation of new treatments. However, research in HRQoL among patients with gliomas is scarce compared to the other categories of patients with tumors. In recent years have exercise become an important part of cancer treatment. The effects is well documented in studies among other cancer patients than gliomas and includes improvements of quality of life, physical function, reduce fatigue and thereby supports daily activities among cancer patients'. Inpatient rehabilitation studies among glioma patients have also indicated improved HRQoL and functional measurements such as activity of daily life, mobility and cognition. Despite of this rehabilitation efforts is still not emphasized in this population and recent literature concludes that there are no well-designed clinical studies examining the effect of multidisciplinary rehabilitation among Glioma patients. This study is the first to investigate the effect of an intensive specialised interdisciplinary outpatient rehabilitation program among gliomas patients.

Interventions

Sponsors

University of Southern Denmark
CollaboratorOTHER
Odense University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of primary glioma (WHO grades I-IV) * Age ≥ 18 * Reference with diagnosis or treatment at Odense University Hospital * Karnofsky performance score (KPS) ≥70 * Ability to understand Danish.

Exclusion criteria

* Pregnancy * Known psychiatric diagnosis or substance abuse * Heart problems excluding intense exercise (NYHA group III and IV) * Pronounced impressive/expressive aphasia

Design outcomes

Primary

MeasureTime frameDescription
Health related quality of lifeChange from Baseline HRQoL at 6 monthsQuestionnaires EORTC-QLQ-30 & BN-20

Secondary

MeasureTime frameDescription
Physical activity levelsChange from Baseline Physical activity levels at 6 monthsPhysical activity at work and leisure time ( Assessed through questionnaire by Saltin and Grimsby 1968 and Physical Activity Scale)
Muscle strengthChange from Baseline Musclestrength at 3 monthsAssessed through 3-8 submax repetition maximum
VO2peakChange from Baseline VO2peak at 3 monthsAssessed through Åstrand 1-pkt. cycle test.
Symptom burdenChange from Baseline Symptom burden at 6 monthsAssessed through EORTC-QLQ-30 & BN-20
Gait functionChange from Baseline gait function at 3 monthsAssessed through 10 meter walk test. Time and step frequency.
Activity levelsChange from Baseline Activity levels at 3 monthsAssessed through questionnaire (Impact on Participation and Autonomy)
BalanceChange from Baseline Balance at 3 monthsAssessed through wii balance board

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026